Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV000593624 | SCV000700222 | pathogenic | Achromatopsia | 2018-03-20 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001048868 | SCV001212893 | uncertain significance | not provided | 2023-07-17 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on CNGA3 function (PMID: 17693388). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CNGA3 protein function. ClinVar contains an entry for this variant (Variation ID: 503562). This missense change has been observed in individual(s) with achromatopsia (PMID: 11536077). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 406 of the CNGA3 protein (p.Met406Thr). |